Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | GAA | P10253 | 3/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | JAK2 | O60674 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4180647 | 0.87 | LMNA (0.48) | ALDH1A1MAPTGAAL3MBTL1NPSR1 | |
| SCHEMBL15357251 | 0.85 | GAA (0.56) | ALDH1A1CYP1A2CYP3A4CYP2C8CYP2C9 | |
| SCHEMBL24135768 | 0.84 | GAA (0.43) | ALDH1A1CYP1A2CYP3A4CYP2C8CYP2C9 | |
| SCHEMBL19442903 | 0.84 | ALDH1A1 (0.57) | ALDH1A1GAAL3MBTL1LMNAMEN1 | |
| SCHEMBL11382179 | 0.83 | GAA (0.51) | ALDH1A1CYP1A2CYP3A4CYP2C8CYP2C9 | |
| SCHEMBL10922927 | 0.83 | BACE1 (0.52) | ALDH1A1CYP1A2CYP3A4CYP2C8CYP2C9 | |
| SCHEMBL15349839 | 0.83 | LMNA (0.47) | ALDH1A1CYP1A2CYP3A4CYP2C8CYP2C9 | |
| SCHEMBL24080812 | 0.82 | GAA (0.50) | ALDH1A1CYP3A4MAPTGAAL3MBTL1 | |
| SCHEMBL28266853 | 0.81 | GAA (0.48) | ALDH1A1CYP1A2CYP3A4CYP2C8CYP2C9 | |
| SCHEMBL13812603 | 0.80 | ALDH1A1 (0.43) | ALDH1A1MAPTGAAL3MBTL1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115974828-B | Compounds as protein phosphatase 5 agonists, methods of preparation and uses thereof | 中国药科大学 | 2025-02-11 | — | — | CN | disclosed |
| CN-115974828-A | Compound as protein phosphatase 5 agonist and preparation method and application thereof | 中国药科大学 | 2023-04-18 | — | — | CN | disclosed |
| CN-109535185-A | One kind is using 4-(4- methyl piperidine) -3- thiosemicarbazones is the gold complex of ligand and its synthetic method and application | 广西师范大学 | 2019-03-29 | — | — | CN | disclosed |
| US-9375434-B2 | Antitumor effect potentiator composed of imidazooxazine compound | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2016-06-28 | — | — | US | disclosed |
| US-9375434-B2 | Antitumor effect potentiator composed of imidazooxazine compound | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2016-06-28 | — | — | US | disclosed |
| US-9289431-B2 | — | — | 2016-03-22 | — | — | US | disclosed |
| US-9289431-B2 | — | — | 2016-03-22 | — | — | US | disclosed |
| EP-2698372-B1 | NOVEL IMIDAZO-OXAZINE COMPOUND OR SALT THEREOF | TAIHO PHARMACEUTICAL CO LTD (JP) | 2016-02-03 | — | — | EP | disclosed |
| US-9187510-B2 | Light-emitting organic platinum complex, light-emitting material containing this complex and functional device | OSAKA UNIVERSITY (JP) | 2015-11-17 | — | — | US | disclosed |
| US-20150164909-A1 | ANTITUMOR EFFECT POTENTIATOR COMPOSED OF IMIDAZOOXAZINE COMPOUND | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2015-06-18 | — | — | US | disclosed |
| US-8772283-B2 | Imidazo-oxazine compound or salt thereof | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2014-07-08 | — | — | US | disclosed |
| EP-2698372-A1 | NOVEL IMIDAZO-OXAZINE COMPOUND OR SALT THEREOF | Taiho Pharmaceutical Co., Ltd. (JP) | 2014-02-19 | — | — | EP | disclosed |
| WO-2014007217-A1 | ANTITUMOR EFFECT POTENTIATOR COMPOSED OF IMIDAZOOXAZINE COMPOUND | 大鵬薬品工業株式会社 (JP) | 2014-01-09 | — | — | WO | disclosed |
| US-20130001535-A1 | LIGHT-EMITTING ORGANIC PLATINUM COMPLEX, LIGHT-EMITTING MATERIAL CONTAINING THIS COMPLEX AND FUNCTIONAL DEVICE | OSAKA UNIVERSITY (JP) | 2013-01-03 | — | — | US | disclosed |
| WO-2012137870-A1 | NOVEL IMIDAZO-OXAZINE COMPOUND OR SALT THEREOF | 大鵬薬品工業株式会社 (JP) | 2012-10-11 | — | — | WO | disclosed |
| US-7745229-B2 | Chemoselective fluorgenic molecular linkers and methods for their preparation and use | UNIVERSITY OF SOUTH CAROLINA | 2010-06-29 | — | — | US | disclosed |
| US-20070224695-A1 | Chemoselective Fluorgenic Molecular Linkers and Methods for Their Preparation and Use | UNIVERSITY OF SOUTH CAROLINA (US) | 2007-09-27 | — | — | US | disclosed |
| WO-2005103705-A2 | CHEMOSELECTIVE FLUOROGENIC MOLECULAR LINKERS AND METHODS OF THEIR PREPARATION AND USE | UNIVERSITY OF SOUTH CAROLINA (US) | 2005-11-03 | — | — | WO | disclosed |
| US-4399148-A | SYSTEMIC PESTICIDES; APHIDICIDES | UNION CARBIDE CORPORATION (US) | 1983-08-16 | — | — | US | disclosed |
| EP-0067503-A1 | Hydroxyaryliminoaryl carbamates, imine bisphenols and derivatives thereof useful as insecticidal compositions | UNION CARBIDE CORPORATION (US) | 1982-12-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150164909-A1 | ANTITUMOR EFFECT POTENTIATOR COMPOSED OF IMIDAZOOXAZINE COMPOUND | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HCCS, TPD52L2 | ALDH1A1 955/4885CYP1A2 1022/4885CYP3A4 1675/4885 |
| US-20070224695-A1 | Chemoselective Fluorgenic Molecular Linkers and Methods for Their Preparation and Use | KIT, HLCS, ALK | ALDH1A1 1386/4885CYP1A2 4438/4885CYP3A4 3293/4885 |
| US-20130001535-A1 | LIGHT-EMITTING ORGANIC PLATINUM COMPLEX, LIGHT-EMITTING MATERIAL CONTAINING THIS COMPLEX AND FUNCTIONAL DEVICE | CRY2, C9, PMS2 | ALDH1A1 1500/4885CYP1A2 440/4885CYP3A4 2105/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.